Mein Warenkorb

HSV-gC

Produktanfrage

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
WSD-0922WSD0922; WSD-0922Phase 2 ClinicalWayshine Biopharm International LtdGlioblastoma; Neoplasms; Astrocytoma; Carcinoma, Non-Small-Cell Lung
Details
Anti-EGFRvIII-CAREGFRvIII CAR; Anti-EGFRvIII-CARPhase 2 ClinicalNational Cancer InstituteGlioblastoma; Brain Neoplasms; Gliosarcoma; Glioma
Details
Recombinant anti-EGFR chimeric monoclonal antibody (Shanghai CP Guojian)CPGJ-602; 602; CPGJ602; CPGJ 602Phase 2 ClinicalSunshine GuoJian Pharmaceutical (Shanghai) Co LtdColorectal Neoplasms
Details
EGFRvIII-directed CAR-T cell tharapy (Novartis/University of Pennsylvania)LXF-821Phase 1 ClinicalUniversity Of Pennsylvania, Novartis Pharma AgGlioblastoma
Details
EGFRvIII-CARPhase 1 ClinicalDuke University Medical CenterGlioblastoma
Details
APTN-101APTN 101Phase 1 ClinicalGlioblastoma
Details
Autologous Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13R alpha2 CAR (E-SYNC) T Cells therapy(California Institute For Regenerative Medicine)Phase 1 ClinicalCalifornia Institute For Regenerative Medicine, National Cancer InstituteGlioblastoma
Details
Targeted EGFRvIII autochimeric antigen receptor T cell therapy (DCTY)DCTY0801; DCTY-0801Phase 1 ClinicalBeijing DCTY Biotech Co LtdGlioblastoma
Details
SNC-109SNC109; SNC-109Phase 1 ClinicalShanghai Simnova Biotechnology Co LtdGlioblastoma
Details
RO-7428731RO-7428731; RG-6156Phase 1 ClinicalF. Hoffmann-La Roche LtdGlioblastoma
Details
hEGFRvIII-CD3 Bi-scFvPhase 1 ClinicalDuke UniversityGlioblastoma; Glioma
Details
GNC-039GNC-039Phase 1 ClinicalSolid tumours; Hematologic Neoplasms; Glioma; Neoplasm Metastasis
Details
EtevritamabAMG-596Phase 1 ClinicalAmgen IncGlioblastoma
Details
  • Produktanfrage
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns